Last reviewed · How we verify
new formulations of 611 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
new formulations of 611 (new formulations of 611) — Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| new formulations of 611 TARGET | new formulations of 611 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- new formulations of 611 CI watch — RSS
- new formulations of 611 CI watch — Atom
- new formulations of 611 CI watch — JSON
- new formulations of 611 alone — RSS
Cite this brief
Drug Landscape (2026). new formulations of 611 — Competitive Intelligence Brief. https://druglandscape.com/ci/new-formulations-of-611. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab